跳至主要内容
临床试验/NCT03939247
NCT03939247终止不适用

Effectiveness of High Frequency Currents (Tecarethérapie) in Patients With Lateral Elbow Tendonopathy

University of Liege2 个研究点 分布在 1 个国家目标入组 17 人开始时间: 2019年4月25日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
17
试验地点
2
主要终点
change in the "Patient-Rated Tennis Elbow Evaluation" score

研究概览

简要总结

This RCT aims at investigating the effectiveness of the "Tecaretherapy" in patients with lateral elbow tendinopathy.

60 patients will be randomized into one of the following 3 groups:

  • "Conventional physiotherapy treatment (CPT)" (massage, eccentric exercises, stretching);
  • "CPT + Tecare" (idem CPT group + tecaretherapy during the eccentric exercises)
  • "CPT + Placebo Tecare" (idem "CPT + Tecare" group but with an inactive Tecare device) The treatment will include 18 30-minute sessions

详细描述

This RCT aims at investigating the effectiveness of the "Tecaretherapy" in patients with lateral elbow tendinopathy.

60 patients will be randomized into one of the following 3 groups:

  • "Conventional physiotherapy treatment (CPT)" (massage, eccentric exercises by means of an isokinetic dynamometer, stretching);
  • "CPT + Tecare" (idem CPT group + Tecaretherapy during the eccentric exercises)
  • "CPT + Placebo Tecare" (idem "CPT + Tecare" group but with an inactive "Tecare" device) The treatment will include 18 30-minute sessions.

The "Tecaretherapy" consists in using a specific device providing high frequencies (between 300 kHz and 1 MHz) supposed to accelerate the tissues healing process.

Outcome sessions will be organized at baseline, after the first 9 sessions, at the end of the treatment as well as 3 and 6 months after the initial treatment session.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

盲法说明

The patients receiving the "Placebo Tecare" will be blinded by using an identical device as in the active group but which cannot provide any current

入排标准

年龄范围
18 Years 至 55 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Patient suffering from a chronic lateral elbow tendinopathy confirmed by echography

排除标准

  • with contra-indications for a Tecaretherapy (Pace maker, insuline pump, pregnancy, infection, fever, cancer, thrombophlebitis)
  • reporting injections and/or shockwaves in the past (for the tendinopathy)
  • with an associated neurogenic dysfunction

结局指标

主要结局

change in the "Patient-Rated Tennis Elbow Evaluation" score

时间窗: up to 6 months

This questionnaire, developped for patients with elbow tendinopathy, consists of one part dealing with pain and a second part dealing with function. Each of the 5 items in part 1 is scored using a NRS, ranging from 0 (no pain) to 10 (worst pain imaginable). Part 2 is subdivided into Specific Activities (6 items) and Usual Activities (4 items). The 10 items of part 2 use a scale of 0 (no difficulty) to 10 (unable to perform an activity) to rate function. The total score is the combined score that rates pain and disability of equal importance. The pain score total (out of 50 points) and the functional subscale (60 points for specific activities, plus 40 points for usual activities to give a function subscale out of 100 points /2 to provide the remaining 50%) provide a total score, ranging from 0 (no pain and no functional impairment) to 100 (worst pain imaginable with a very significant functional deficit).

次要结局

  • change in pain Intensity(up to 6 months)
  • change in pain Pressure thresholds(up to 6 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Christophe Demoulin

Associated Professor

University of Liege

研究点 (2)

Loading locations...

相似试验

Effectiveness of the "Tecaretherapy" in Patients... | 临床试验